<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OF
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 0-15271
CISTRON BIOTECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
239 New Road, Building B, Suite 202
Parsippany, New Jersey 07054
(973) 575-1700
(Address, including zip code, and telephone number, including
area code, of Registrant's principal executive offices)
Common Stock ($.01 par value)
(Title of each class of securities covered by this Form)
None
(Title of all other classes of securities for which a duty to
file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) |X| Rule 12h-3(b)(1)(ii) |_|
Rule 12g-4(a)(1)(ii) |_| Rule 12h-3(b)(2)(i) |_|
Rule 12g-4(a)(2)(i) |_| Rule 12h-3(b)(2)(ii) |_|
Rule 12g-4(a)(2)(ii) |_| Rule 15d-6 |X|
Rule 12h-3(b)(1)(i) |_|
Approximate number of holders of record as of the certification or
notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Cistron
Biotechnology, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
CISTRON BIOTECHNOLOGY, INC.
Date: November 6, 2000 By: /s/ John A.D. Slater
----------------------------------
Name: John A.D. Slater
Title: Secretary
